preventing gout flares when urate lowering therapy
A recent meta-analysis confirmed that gout needs to be treated with anti-inflammatory meds for longer than three months after initiating urate-lowering meds in order to decrease the risk of a recurrent flare (see gout flares high after stopping prophy ArthCareRes2024 in dropbox, or DOI 10.1002/acr.25486) Details: --researchers found 6 trials in the literature and one with aggregated unpublished data from the VA (the VA STOP Gout trial), with a total of 2972 participants -- these trials were chosen because they had at least one study arm with starting or intensifying urate-lowering therapy (ULT) in which anti-inflammatory prophylaxis was prescribed; these included trials needed to report the percentage of participants with at least one gout flare both during and after the period of anti-inflammatory prophylaxis was documented -- trial durations ranged from 24 to 104 weeks, and anti-inflammatory prophylaxis durations ...